Active, not recruitingPhase 2NCT05456087

Use of Botulinum Toxin in the Treatment of Androgenic Alopecia

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Zel Skin and Laser Specialists
Intervention
incobotulinumtoxin A(drug)
Enrollment
20 target
Eligibility
22-55 years · All sexes
Timeline
20222024

Study locations (1)

Collaborators

Merz Aesthetics Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05456087 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials